Evidence map›Paper›PMID 38543927›Full record

ArticleVaccines2024

Factors Involved in the Immunological Protection against Rabies Virus in Dogs in Spain.

María Dolores Manzano, Javier Cereza, Jesús García, Luis Javier Yus, Juan José Badiola, Juan Emilio Echevarria, Marta Monzón

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

María Dolores ManzanoResearch Centre for Encephalopathies and Transmissible Emerging Diseases, Institute for Health Research Aragón (IIS), University of Zaragoza, 50013 Zaragoza, Spain.
Javier CerezaCentro Técnico Veterinario (Diputación de Zaragoza), 22002 Zaragoza, Spain.
Jesús GarcíaColegio Oficial de Veterinarios de Zaragoza, 50010 Zaragoza, Spain.
Luis Javier YusColegio Oficial de Veterinarios de Zaragoza, 50010 Zaragoza, Spain.
Juan José BadiolaResearch Centre for Encephalopathies and Transmissible Emerging Diseases, Institute for Health Research Aragón (IIS), University of Zaragoza, 50013 Zaragoza, Spain.
Juan Emilio EchevarriaCentro Nacional de Microbiología, Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.ORCID 0000-0001-7522-850X
Marta MonzónResearch Centre for Encephalopathies and Transmissible Emerging Diseases, Institute for Health Research Aragón (IIS), University of Zaragoza, 50013 Zaragoza, Spain.ORCID 0000-0002-2787-9671
Universidad de Zaragoza · ESInstituto de Salud Carlos III · ESUniversidad Nacional de Educación a Distancia · ES

Funding

Gobierno de Aragón 0359
6 · The paper itself

Abstract

Rabies, a viral disease spread by infected animal bites that causes encephalitis in humans and other mammals, is a neglected infectious disease present on all continents except Antarctica. Spain has been free of terrestrial rabies since 1978. However, due to its geographical situation, it represents a bridge for imported cases from an endemic continent such as Africa to Europe. Rabies vaccination in dogs is an essential preventive tool against this zoonosis. The aim of this study was to determine the state of the immune response against rabies virus in dogs in Spain and to demonstrate whether several factors that have been previously related to the influence of the seroprevalence of this species are involved here. The seroconversion level of this zoonotic virus was assessed in a total of 1060 animals. Indirect ELISA was used to obtain data for statistical analysis to evaluate the studied variables. Working under the concept of One Health, this study provides relevant information to be taken into consideration not only to prevent re-emergence in countries free of this disease but also for prevention and control in endemic countries.

Indexed as

factors affecting seroprevalenceimmune protection against rabies virus in dogsOne Healthrabies vaccineserum antibodies

Identifiers

PMID38543927
PMCPMC10976103
OpenAlexW4392709213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.